星宣次:ホルモン抵抗性前立腺癌に対するCDDP, UFT, diethylstilbestrol, dexamethasone (CUDD)療法、pp49-58, in Advances in cancer treatment(24) がん治療のあゆみ、2004/第24回一般研究助成,がん集学的治療研究財団
Namiki S, Saito S, Ishidoya S, Tochigi T, Ioritani N, Yoshimura K, Terai A, and Arai Y: Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms. Urology 66(1): 147-151, 2005.
Namiki S, Saito S, Satoh M, Ishidoya S, Kawamura S, Tochigi T, Kuwahara M, Aizawa M, Ioritani N, Yoshimura K, Ichioka K, Terai A and Arai Y: Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study. Jpn.J.Clin.Oncol 35(9): 551-558, 2005.
Namiki S, Saito S, Tochigi T, Kuwahara M., Ioritani N, Yoshimura K, Teraa A, Koinuma N and Arai Y: Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life. Int.J.Urol: 12:173-181, 2005.
Namiki S, Egawa S, Baba S, Terachi T, Usui Y, Terai, A, Tochigi T, Kuwahara, M. Iotitani N and Arai Y: Recovery of quality of life in year after laparoscopic or retropubic radical prostatectomy: a multi-institutional longitudinal study. Urology 65: 517-523, 2005.
Namiki, S, Saito S, Ishidoya S, Kawamura S, Tochigi T, Kuwahara M, Aizawa M, Yoshimura K, Ichioka K, Terai A and Arai Y: An evaluation of urinary function after radical prostatectomy in Japanese men:concordance with definition of urinary continence. BJU Int, 95: 530-3, 2005.
Namiki S, Terai A, Nakagawa H, Ikeda Y, Saito S, Satoh M, Ishidoya S, Yoshimura K, Ichioka K and Arai Y: Intraoperative electrophysiological confirmation of neurovascular bundle preservation during radical prostatectomy: long-term assessment of urinary and sexual function. Jpn J Clin Oncol 35: 660-666, 2005.
Gao HW, Li YL, Wu S, Wang YS, Zhang HF, Pan YZ, Zhang L, Tateno H, Sato I, Kuwahara M, Zhao XJ: Mass screening of prostate cancer in a Chinese population: the relationship] between pathological features of prostate cancer and serum prostate specific antigen. Asian J Androl 7: 159-63, 2005
Li XM, Zhang L, Li J, Li Y, Wang HL, Ji GY, Kuwahara M, Zhao XJ: Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL. Asian J Androl., 7: 323-8, 2005.
Saito S, Egawa S, Endoh M, Ueno S, Ito A, Numahata K, Satoh M, Kuwao S, Baba S, Hakomori S, Arai Y: RM2 antigen (-1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer. Int J Cancer 115: 105-113, 2005.
Satoh M, Ito A, Kaiho Y, Nakagawa H, Saito S, Endo M, Ohyama C, Arai Y: Intraoperative, radio-guided sentinel lymph node mapping in laparoscopic lymph node dissection for stage I testicular carcinoma. Cancer 103: 2067-2072, 2005.
Iwai K, Shi Y-W, Matsuura Y, Miyagi M, Saito S, and Arai Y: Characteristics of calculus fragmentation using Er:TAG laser light emitted by an IR hollow optical fiber with various sealing caps. Applied Optics 44 (16): 3266-3270, 2005.
Ishidoya S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, Arai Y: Laparoscopic partial versus total adrenalectomy for Aldosterone-producing adenoma. J Urol 174(1): 40-43, 2005.
Kaiho Y, Nakagawa H, Ikeda Y, Namiki S, Numahata K, Satoh M, Saito S, Yoshimura K, Terai A, Arai Y.: Intraoperative electrophysiological confirmation of urinary continence after radical prostatectomy J Urol. 2005 Apr;173(4):1139-42.
Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S: A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of -3-1 integrin with CD9 J Biol Chem. 21;280(42):35545-53 2005.
Katahira A, Niikura H, Kaiho Y, Nakagawa H, Kurokawa K, Arai Y, Yaegashi N.: Intraoperative electrical stimulation of the pelvic splanchnic nerves during nerve-sparing radical hysterectomy Gynecol Oncol. Sep: 98(3):462-6 2005.
Namiki S, Saito S, Ishidoya S, Tochigi T, Ioritani N, Yoshimura K, Terai A Arai Y: Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms Urology 5:66(1):147-51 2005
Hagisawa S, Ohyama C, Takahashi T, Endoh M, Moriya T, Nakayama J, Arai Y and Fukuda M: Expression of core 2 β1,6-N-acetylglucosaminyltransferase facilitates prostate Glycobiology 15(10): 1016-1024, 2005
Terai A, Matsui Y, Yoshimura K, A Yoichi and Dodo Y: Salvage radiotherapy for biochemical recurrence after radical prostatectomy BJU Int 96(7): 1009-1013, 2005.
Terai A, Terada N, Yoshimura K, Ichioka K, Ueda N, Utsunomiya N, Kohei N, Arai Y and Yonei A: USE OF ACUTE NORMOVOLEMIC HEMODILUTION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY Urology 65(6): 1152-1156, 2005.
Segawa T, Kamoto T, Kinoshita H, Kunishima Y, Yoshimura K, Ito A, Takahashi T, Higashi S, Nakamura E, Nishiyama H, Ito N, Yamamoto S, Habuchi T, Ogawa O: Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer.Int J Clin Oncol. Oct;10(5):333-7, 2005.
Nakamura Y, Suzuki T, Nakabayashi M, Endoh M, Sakamoto K, Mikami Y, Moriya T, Ito A, Takahashi S, Yamada S, Arai Y, Sasano H. In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer. Mar: 12(1):101-7, 2005.
S Saito, S Egawa, M Endoh, S Ueno, A Ito, K Numahata, M Satoh, S Kuwao, S Baba, Y Arai, S Hakomori: RM2 antigen (beta 1,4-GalNAc-disialyl Lc4) as a new marker for prostate cancer. J Urol 173: 124, 2005.